Tarenflurbil: a shot on goal

Lancet Neurol. 2008 Jun;7(6):468-9. doi: 10.1016/S1474-4422(08)70091-7. Epub 2008 Apr 29.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / enzymology
  • Alzheimer Disease / physiopathology
  • Amyloid Precursor Protein Secretases / antagonists & inhibitors*
  • Amyloid Precursor Protein Secretases / metabolism
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Brain / drug effects
  • Brain / enzymology
  • Brain / physiopathology
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic / standards
  • Clinical Trials, Phase III as Topic / statistics & numerical data
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Flurbiprofen / pharmacology*
  • Flurbiprofen / therapeutic use
  • Humans
  • Plaque, Amyloid / drug effects
  • Plaque, Amyloid / enzymology
  • Treatment Outcome

Substances

  • Amyloid beta-Peptides
  • Anti-Inflammatory Agents, Non-Steroidal
  • Enzyme Inhibitors
  • Flurbiprofen
  • Amyloid Precursor Protein Secretases